Switzerland· 00671003
Fibrogammin 250 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
A medicinal product, registered in Switzerland by CSL Behring AG and dispensed under Swissmedic category B.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Manufacturer
- CSL Behring AG
- Country
- Switzerland (CH)
- ATC code
- —
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 4, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de648be0-a39e-4195-a324-890647b804ed GET /v1/drugs/de648be0-a39e-4195-a324-890647b804ed?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Blutprodukte"
}See everything about Fibrogammin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.